Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies

Journal of Clinical Neuroscience

Volumn 19, Issue 11, 2012, Pages 1471-1474

  Colditz, Michael J ^a   Jeffree, Rosalind L ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

ALA; Aminolevulinic acid; Fluorescence guided resection; Gliolan; Glioma; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; GADOLINIUM; PROTOPORPHYRIN;

BLUE LIGHT; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; DETERIORATION; FLUORESCENCE; FLUORESCENCE GUIDED RESECTION; FLUORESCENCE SPECTROSCOPY; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAOPERATIVE PERIOD; KARNOFSKY PERFORMANCE STATUS; MENINGIOMA; MICROSURGERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REOPERATION; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TUMOR GROWTH; WHITE LIGHT;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FLUORESCENCE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PHOTOSENSITIZING AGENTS; POSITRON-EMISSION TOMOGRAPHY; PROTOPORPHYRINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGERY, COMPUTER-ASSISTED;

EID: 84867099481     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.03.009     Document Type: Review

References (46)

1. M.J. McGirt, K.L. Chaichana, and M. Gathinji Independent association of extent of resection with survival in patients with malignant brain astrocytoma J Neurosurg 110 2009 156 162
2. M. Lacroix, D. Abi-Said, and D.R. Fourney A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2001 190 198
3. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
4. G.E. Keles, B. Anderson, and M.S. Berger The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere Surg Neurol 52 1999 371 379
5. C. Nimsky, A. Fujita, and O. Ganslandt Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging Neurosurgery 55 2004 358 370 [discussion 70-1]
6. W.B. Pope, J. Sayre, and A. Perlina MR imaging correlates of survival in patients with high-grade gliomas AJNR Am J Neuroradiol 26 2005 2466 2474
7. W. Stummer, U. Pichlmeier, and T. Meinel Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 2006 392 401
8. J.H. Sherman, K. Hoes, and J. Marcus Neurosurgery for brain tumors: update on recent technical advances Curr Neurol Neurosci Rep 11 2011 313 319
9. C. Senft, A. Bink, and K. Franz Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial Lancet Oncol 12 2011 997 1003
10. C. Senft, K. Franz, and S. Blasel Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme Technol Cancer Res Treat 9 2010 339 346
11. H.M. Mehdorn, F. Schwartz, and S. Dawirs High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient? Acta Neurochir Suppl 109 2011 103 106
12. W. Stummer, A. Novotny, and H. Stepp Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients J Neurosurg 93 2000 1003 1013
13. W. Stummer, H.J. Reulen, and T. Meinel Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 62 2008 564 576 [discussion -76]
14. C.B. Scott, C. Scarantino, and R. Urtasun Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06 Int J Radiat Oncol Biol Phys 40 1998 51 55
15. U. Pichlmeier, A. Bink, and G. Schackert Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro Oncol 10 2008 1025 1034
16. R. Diez Valle, S. Tejada Solis, and M.A. Idoate Gastearena Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience J Neurooncol 102 2011 105 113
17. W. Stummer, J.C. Tonn, and H.M. Mehdorn Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article J Neurosurg 114 2011 613 623
18. S.M. Chang, I.F. Parney, and M. McDermott Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project J Neurosurg 98 2003 1175 1181
19. C. Ewelt, F.W. Floeth, and J. Felsberg Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence Clin Neurol Neurosurg 113 2011 541 547
20. M. Hefti, G. von Campe, and M. Moschopulos 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion Swiss Med Wkly 138 2008 180 185
21. R. Ishihara, Y. Katayama, and T. Watanabe Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas Neurol Med Chir (Tokyo) 47 2007 53 57 [discussion 7]
22. D.W. Roberts, P.A. Valdes, and B.T. Harris Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article J Neurosurg 114 2011 595 603
23. F. Stockhammer, M. Misch, and P. Horn Association of F18-fluoro-ethyl- tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas Acta Neurochir (Wien) 151 2009 1377 1383
24. W. Stummer, H. Stepp, and G. Moller Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue Acta Neurochir (Wien) 140 1998 995 1000
25. S. Utsuki, H. Oka, and S. Sato Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance Neurol Med Chir (Tokyo) 47 2007 210 213 [discussion 3-4]
26. G. Widhalm, S. Wolfsberger, and G. Minchev 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement Cancer 116 2010 1545 1552
27. W. Stummer, S. Stocker, and S. Wagner Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrins fluorescence Neurosurgery 42 1998 518 525
28. R. Ishihara, Y. Katayama, and T. Watanabe Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas Neurol Med Chir (Tokyo) 47 2007 53 57
29. M.A. Idoate, R. Diez Valle, and J. Echeveste Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence Neuropathology 31 2011 575 582
30. S. Utsuki, N. Miyoshi, and H. Oka Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study Brain Tumor Pathol 24 2007 53 55
31. F.W. Floeth, M. Sabel, and C. Ewelt Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas Eur J Nucl Med Mol Imaging 38 2011 731 741
32. S. Moriuchi, K. Yamada, and M. Dehara Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases J Neurosurg 115 2011 278 280
33. S. Utsuki, H. Oka, and K. Sato Fluorescence diagnosis of tumor cells in hemangioblastoma cysts with 5-aminolevulinic acid J Neurosurg 112 2010 130 132
34. S. Miyatake, T. Kuroiwa, and Y. Kajimoto Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report Neurosurgery 61 2007 E1101 E1103 [discussion E3-4]
35. S. Eicker, S. Sarikaya-Seiwert, and A. Borkhardt ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery Cen Eur Neurosurg 72 2011 101 103
36. M. Rapp, M. Klingenhofer, and J. Felsberg Fluorescence-guided resection of spinal metastases of malignant glioma - report of 2 cases Cent Eur Neurosurg 2011
37. D. Coluccia, J. Fandino, and M. Fujioka Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas Acta Neurochir (Wien) 152 2010 1711 1719
38. Y. Kajimoto, T. Kuroiwa, and S. Miyatake Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence Case report. J Neurosurg 106 2007 1070 1074
39. Y. Morofuji, T. Matsuo, and Y. Hayashi Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report Neurosurgery 62 2008 102 103 [discussion 3-4]
40. J. Ayerbe, R.D. Lobato, and J. de la Cruz Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis Acta Neurochir (Wien) 141 1999 921 932
41. A. Johansson, G. Palte, and O. Schnell 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors Photochem Photobiol 86 2010 1373 1378
42. P.A. Valdés, A. Kim, and M. Brantsch 5-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy Neuro Oncol 13 2011 846 856
43. P.A. Valdes, F. Leblond, and A. Kim Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker J Neurosurg 115 2011 11 17
44. J.W. Henson, S. Ulmer, and G.J. Harris Brain tumor imaging in clinical trials AJNR Am J Neuroradiol 29 2008 419 424
45. B.J. Pirotte, M. Levivier, and S. Goldman Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients Neurosurgery 64 2009 471 481 [discussion 81]
46. P.A. Valdes, X. Fan, and S. Ji Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection Stereotact Funct Neurosurg 88 2010 1 10